End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57,400 KRW | -0.17% | 0.00% | -20.28% |
03-28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
03-07 | SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline | CI |
Sales 2024 * | 246B 179M 244M | Sales 2025 * | 320B 233M 318M | Capitalization | 4,410B 3.21B 4.38B |
---|---|---|---|---|---|
Net income 2024 * | -38B -27.63M -37.73M | Net income 2025 * | -18B -13.09M -17.87M | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | 200B 146M 199M | Net cash position 2025 * | 498B 362M 495M | EV / Sales 2025 * | 12.2 x |
P/E ratio 2024 * |
-114
x | P/E ratio 2025 * |
-239
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.48% |
1 day | -0.17% | ||
Current month | -6.36% | ||
1 month | -7.42% | ||
3 months | -9.61% | ||
6 months | -2.21% | ||
Current year | -20.28% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 16 M€ | -8.49% | ||
0.04% | 15 M€ | +11.24% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 57,400 | -0.17% | 44,480 |
24-04-25 | 57,500 | -1.37% | 44,001 |
24-04-24 | 58,300 | 0.00% | 38,504 |
24-04-23 | 58,300 | -0.34% | 44,314 |
24-04-22 | 58,500 | +1.92% | 41,381 |
End-of-day quote Korea S.E., April 25, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.28% | 3.2B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- A302440 Stock